Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

NCT00657007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: belimumab
BIOLOGICAL: belimumab
BIOLOGICAL: belimumab
BIOLOGICAL: belimumab
BIOLOGICAL: Placebo

Sponsor

Human Genome Sciences Inc.